Guidelines International Network | Guidelines International Network (GIN)

Systemic therapy for recurrent, metastatic, or persistent cervical cancer

MeSH Terms: Drug Therapy; Combination (E02.319.310); Meta-Analysis as Topic (E05.581.500.501); Drug Therapy (E02.319)
Guideline Contact: Cindy Walker-Dilks (pebconc@mcmaster.ca)
Publication Scope: treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: McMaster University (CA)
Publication Year: 2014

MeSH Terms: Consensus Development Conference (V03.300); Consensus (F01.829.316.068); Myelodysplastic Syndromes (C15.378.190.625)
Guideline Contact: Cindy Walker-Dilks (pebconc@mcmaster.ca)
Publication Scope: treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: McMaster University (CA)
Publication Year: 2018

MeSH Terms: Neuroendocrine Carcinoma, Gastroenteropancreatic neuroendocrine tumor, Phase 3 Clinical Trial, Phase 4 Clinical Trial, Randomized Controlled Trial, Guideline, Systematic Review, Quality Assessment, Adult, Octreotide, 177Lu-Dotatate, 90y-Dotatate
Guideline Contact: Roxanne Cosby; cosbyr@mcmaster.ca
Keywords: Guideline, Midgut Neuroendocrine Tumours, Pancreatic Neuroendocrine Tumours, Systemic Therapy, Systematic Review
Date for Review: The Program in Evidence-based Care (PEBC), Ontario Health (CCO) has an annual review process for each guideline. Guidelines are reviewed every fall, one year after they are completed
Publication Date: March 2024
Date of Last Evidence Search: October 30, 2023
Methods Applied: Evidence-based; Systematic review-based; External review; Evidence quality assessment; Patient/survivor/caregiver participation
Publication Scope: treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: PEBC (Program in evidenced-based care)
Publication Year: 2024

MeSH Terms: Drug Therapy (E02.319); Antineoplastic Agents (D27.505.954.248); Drug Therapy; Combination (E02.319.310); Prostatic Neoplasms (C04.588.945.440.770)
Guideline Contact: Cindy Walker-Dilks (pebconc@mcmaster.ca)
Publication Scope: treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: McMaster University (CA)
Publication Year: 2005

MeSH Terms: Prostatic Neoplasms; Castration-Resistant (C04.588.945.440.770.500)
Guideline Contact: guidelines@asco.org
Publication Date: 08-Sep-14
Publication Scope: management
Countries of Application: United States
Guideline Publication Status: Published
Languages: English
Authors: ASCO (US)
Publication Year: 2014

MeSH Terms: Randomized Controlled Trial (V03.200.700); Carcinoma; Squamous Cell (C04.557.470.200.400); Hypopharynx (A04.623.490)
Guideline Contact: Cindy Walker-Dilks (pebconc@mcmaster.ca)
Publication Scope: treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: McMaster University (CA)
Publication Year: 2016

MeSH Terms: Consensus Development Conference (V03.300); Consensus (F01.829.316.068); Neuroendocrine Tumors (C04.557.465.625.650); Carcinoid Tumor (C04.557.470.200.025.200)
Guideline Contact: Cindy Walker-Dilks (pebconc@mcmaster.ca)
Publication Scope: treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: McMaster University (CA)
Publication Year: 2016

MeSH Terms: Lupus Erythematosus; Systemic (C17.300.480); Lupus Erythematosus; Systemic (C20.111.590)
Guideline Contact: Ina Kopp (imwi@awmf.org)
English Title Translation: Systemic lupus erythematosus: diagnosis and management
Expected Publication Date: 05/10/2024
Publication Scope: management
Countries of Application: Germany
Guideline Publication Status: Development
Languages: German
Authors: AWMF (DE)